EBF1, MYO6 and CALR expression levels predict therapeutic response in diffuse large B-cell lymphomas
BackgroundDiffuse large B-cell lymphoma (DLBCL) is a hematological malignancy representing one-third of non-Hodgkin’s lymphoma cases. Notwithstanding immunotherapy in combination with chemotherapy (R-CHOP) is an effective therapeutic approach for DLBCL, a subset of patients encounters treatment resi...
Main Authors: | Alice Turdo, Miriam Gaggianesi, Caterina D’Accardo, Gaetana Porcelli, Sebastiano Di Bella, Dario Cricchio, Irene Pillitteri, Rossana Porcasi, Melania Lo Iacono, Francesco Verona, Chiara Modica, Narges Roozafzay, Ada Maria Florena, Giorgio Stassi, Salvatrice Mancuso, Matilde Todaro |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-11-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1266265/full |
Similar Items
-
Cancer Stem Cells in Thyroid Tumors: From the Origin to Metastasis
by: Veronica Veschi, et al.
Published: (2020-08-01) -
Metabolic Escape Routes of Cancer Stem Cells and Therapeutic Opportunities
by: Alice Turdo, et al.
Published: (2020-05-01) -
Dual Inhibition of Myc Transcription and PI3K Activity Effectively Targets Colorectal Cancer Stem Cells
by: Miriam Gaggianesi, et al.
Published: (2022-01-01) -
Role of Type I and II Interferons in Colorectal Cancer and Melanoma
by: Simone Di Franco, et al.
Published: (2017-07-01) -
Targeting of the Peritumoral Adipose Tissue Microenvironment as an Innovative Antitumor Therapeutic Strategy
by: Melania Lo Iacono, et al.
Published: (2022-05-01)